In summary, our study provided potential evidence of the association between MMP9-1562C/T gene promoter polymorphism and the risk of DMI, and supported the hypothesis that the MMP9-1562 T allele variant might be a genetic marker for the risk of DN. This evidence concerns the gene MMP9 and liver dysplastic nodule.